Nonsurgical Management of Ranula with Intralesional Sclerotherapy with 3% Sodium Tetradecyl Sulfate in Pediatric Patients
dc.contributor.author | Mahajan, N | en_US |
dc.contributor.author | Kotwal, B | en_US |
dc.contributor.author | Kaul, B | en_US |
dc.contributor.author | Gupta, A | en_US |
dc.contributor.author | Mahajan, P | en_US |
dc.contributor.author | Shah, SG. | en_US |
dc.date.accessioned | 2025-05-12T08:15:08Z | |
dc.date.available | 2025-05-12T08:15:08Z | |
dc.date.issued | 2024-12 | |
dc.description.abstract | Background: Ranula is a term for mucocele occurring on the floor of the mouth after trauma or obstruction to components of the salivary gland. Surgical method was the only choice of treatment for ranula. However, there are certain limitations of surgical approach. Alternatively, intralesional sclerotherapy with 3% sodium tetradecyl sulfate is newer, simpler and non-invasive treatment procedure. Objective: The objective is to analyze the effect of 3% sodium tetradecyl sulfate (STS) on ranula and to evaluate whether sclerotherapy can be a potent alternative to other surgical treatment modalities. Materials and Methods: This study was carried out among children aged between 7 and 14 years with the chief complaint of swelling in the floor of mouth causing functional impairment and pain in some cases. Surface local anesthesia was applied over the lesion. STS 3% was injected under aseptic conditions with an insulin syringe and this was subsequently repeated on weekly intervals till complete regression. Follow-up was done after every 1, 3, 6 months, and 1 year interval to check for any recurrence. Results: After the first injection of 0.5–1 mL of 3% STS, we observed a complete clinical disappearance of lesion in 9 (31%) cases, a moderate response in 13 (44.9%), and no response in 7 (24.1%) children. Four weeks after the first injection, regression of lesion was observed in all the cases. Conclusion: Sclerotherapy with 3% STS is minimally invasive, safe, and effective treatment of different oral lesions and may be the method of choice in pediatric populations. | en_US |
dc.identifier.affiliations | Assistant Professor and Postgraduate, Department of Pedodontics and Preventive Dentistry, Indira Gandhi Government Dental College and Hospital Amphala, Jammu, Jammu and Kashmir, India | en_US |
dc.identifier.affiliations | MDS, Department of Periodontology | en_US |
dc.identifier.affiliations | Head and Postgraduate, Department of Pedodontics and Preventive Dentistry, Indira Gandhi Government Dental College and Hospital Amphala, Jammu, Jammu and Kashmir, India | en_US |
dc.identifier.affiliations | Associate Professor, Department of Radiology, Government Medical College, Jammu, Jammu and Kashmir, India | en_US |
dc.identifier.affiliations | Assistant Professor, Department of Computer Science, Central University of Jammu, Jammu, Jammu and Kashmir, India | en_US |
dc.identifier.affiliations | Assistant Professor and Postgraduate, Department of Pedodontics and Preventive Dentistry, Maharishi Markendeshwar College of Dental Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Ambala, Haryana, India | en_US |
dc.identifier.citation | Mahajan N, Kotwal B, Kaul B, Gupta A, Mahajan P, Shah SG. . Nonsurgical Management of Ranula with Intralesional Sclerotherapy with 3% Sodium Tetradecyl Sulfate in Pediatric Patients. International Journal of Scientific Study. 2024 Dec; 12(9): 54-60 | en_US |
dc.identifier.issn | 2321-6379 | |
dc.identifier.issn | 2321-595X | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/246963 | |
dc.language | en | en_US |
dc.publisher | International Research Organization for Life & Health Sciences | en_US |
dc.relation.issuenumber | 9 | en_US |
dc.relation.volume | 12 | en_US |
dc.source.uri | https://www.ijss-sn.com/uploads/2/0/1/5/20153321/07_ijss_dec_24_oa05_-_2024.pdf | en_US |
dc.subject | 3% Sodium tetradecyl sulfate | en_US |
dc.subject | Intralesional injection | en_US |
dc.subject | Ranula | en_US |
dc.subject | Sclerosing agents | en_US |
dc.subject | Sclerotherapy | en_US |
dc.title | Nonsurgical Management of Ranula with Intralesional Sclerotherapy with 3% Sodium Tetradecyl Sulfate in Pediatric Patients | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ijss2024v12n9p54.pdf
- Size:
- 1.64 MB
- Format:
- Adobe Portable Document Format